Effect of Oral pH Changes on Smoking Desire
1 other identifier
interventional
82
1 country
1
Brief Summary
Nicotine is a psychoactive substance and its effect is demonstrated by neuronal nicotinic-acetylcholine receptors excreted in the brain and periphery. Psychoactive substances such as nicotine and caffeine play a role in rewarding through the mesolimbic dopaminergic system. The released dopamine produces pharmacological effects that can cause pleasurable emotions. These effects are an important factor in maintaining smoking motivation. The rate of absorption of nicotine from the buccal mucosa, the rate and amount of dependence, significantly affects the risk. In addition to PH, other factors such as local blood flow, product nematode, size and surface area of the tobacco mixture, constant pH holding capacity, and nicotine content of the tobacco can affect nicotine absorption. To facilitate the absorption of nicotine from the buccal mucosa, various substances that increase absorption have been investigated. Increased alkalinity has been shown to increase nicotine absorption and physiological effects by buffering alkaline pH values with moist snuff products and nicotine gums. Although other factors may affect the nicotine absorption rate in oral tobacco, it is stated that the main factor that determines the rate of nicotine absorption is pH. Factors that trigger nicotine use include stress in daily life, daily routines, eating and drinking habits, and especially the use of caffeine. The chronic use of caffeine causes tolerance in many of its effects, and the use of nicotine reduces tolerance effects and also potentiates the effects stimulated through the dopaminergic pathway. It has been reported that smokers consume more caffeine than non-smokers. In the present study, the relationship between oral pH and cigarette demand after caffeine consumption will be investigated. Until now, the relation between cigarette pre- and post-caffeine saliva pH and cigarette smoking has not been investigated. In addition, the effects of drinking behavior and changes in salivary pH on cigarette desire will be investigated and evidence of behavioral methods applied in cigarette smoking cessation treatment will be provided.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2019
CompletedFirst Submitted
Initial submission to the registry
July 19, 2019
CompletedFirst Posted
Study publicly available on registry
July 25, 2019
CompletedJuly 26, 2019
July 1, 2019
8 months
July 19, 2019
July 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To investigate the changes in salivary pH after coffee consumption
salivary pH measurement
30 minutes after intervention
Secondary Outcomes (1)
to investigate how drinking of water affect the smoking desire
30 minutes after intervention
Study Arms (2)
smoking group
OTHER35 smoking case
nonsmoking group
OTHER35 nonsmoking case
Interventions
At room temperature (18-25 ° C) the same place and standard environment will be done. All involved cases will undergo a dental examination and within 30 minutes three samples of saliva will be taken, including first sample, after coffee drink and after drinking water. The pH of samples will be measured and the smoking cessation rate of the smoking cigarette smoker with simultaneous VAS (VISUAL ANALOG SCALA) will be measured. This data will be compared in-house and non-smoking control group
Eligibility Criteria
You may qualify if:
- Not having an active disease
- Be between the ages of 18 and 45
- Not using antibiotics in the last two weeks
- Do not use inhaler treatments
- Not to have an oral or salivary gland disease
- One week after menstrual bleeding in female cases
- At least 10 pack years (P / Y) cigarette story in the case group
You may not qualify if:
- Being an active disease
- \<18 years and\> 45 years old
- Having used antibiotics in the last two weeks
- Use inhaler treatments
- Oral and salivary gland disease
- One week after menstrual bleeding in female cases
- Being in the luteal phase
- Menstrual irregularity
- Being pregnant
- Taking hormonal treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylul University
Izmir, 35340, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, MD
Study Record Dates
First Submitted
July 19, 2019
First Posted
July 25, 2019
Study Start
June 1, 2018
Primary Completion
January 31, 2019
Study Completion
January 31, 2019
Last Updated
July 26, 2019
Record last verified: 2019-07